Top Markets
#1 Black Phoenix Black Phoenix +354.82%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +65.81%
#4 Gold Park Gold Park +62.65%
#5 OpenEden OpenEden +57.93%
#6 BasedHype BasedHype +27.19%
#7 Acurast Acurast +22.84%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +21.46%
#10 Humanity Humanity +17.35%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Advanced Proteome Therapeutics Corporation Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Rangering i aksjer #40426
Advanced Proteome Therapeutics Corporation, operating through its subsidiary... Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Aksjekurs
$0.0002
Sist synkronisert: 2025-05-15
Markedsverdi
$149.63K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel Advanced Proteome Therapeutics Corporation (APTCF)

Kategori

Healthcare
Inntekter for Advanced Proteome Therapeutics Corporation (APTCF)
Inntekter i 2026 TTM: 0
Ifølge Advanced Proteome Therapeutics Corporation sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Advanced Proteome Therapeutics Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE